A Bayesian framework for patient-level partitioned survival cost-utility analysis

by   Andrea Gabrio, et al.

Patient-level health economic data collected alongside clinical trials are an important component of the process of technology appraisal, with a view to informing resource allocation decisions. For end of life treatments, such as cancer treatments, modelling of cost-effectiveness/utility data may involve some form of partitioned survival analysis, where measures of health-related quality of life and survival time for both pre- and post-progression periods are combined to generate some aggregate measure of clinical benefits (e.g. quality-adjusted survival). In addition, resource use data are often collected from health records on different services from which different cost components are obtained (e.g. treatment, hospital or adverse events costs). A critical problem in these analyses is that both effectiveness and cost data present some complexities, including non-normality, spikes, and missingness, that should be addressed using appropriate methods. Bayesian modelling provides a powerful tool which has become more and more popular in the recent health economics and statistical literature to jointly handle these issues in a relatively easy way. This paper presents a general Bayesian framework that takes into account the complex relationships of trial-based partitioned survival cost-utility data, potentially providing a more adequate evidence for policymakers to inform the decision-making process. Our approach is motivated by, and applied to, a working example based on data from a trial assessing the cost-effectiveness of a new treatment for patients with advanced non-small-cell lung cancer.


page 1

page 2

page 3

page 4


A Full Bayesian Model to Handle Structural Ones and Missingness in Economic Evaluations from Individual-Level Data

Economic evaluations from individual-level data are an important compone...

hesim: Health Economic Simulation Modeling and Decision Analysis

Health economic models simulate the costs and effects of health technolo...

Bayesian Nonparametric Cost-Effectiveness Analyses: Causal Estimation and Adaptive Subgroup Discovery

Cost-effectiveness analyses (CEAs) are at the center of health economic ...

BCEA: An R Package for Cost-Effectiveness Analysis

We describe in detail how to perform health economic cost-effectiveness ...

A regression framework for a probabilistic measure of cost-effectiveness

To make informed health policy decisions regarding a treatment, we must ...

An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial

The European Medicines Agency has in recent years allowed licensing of n...

Please sign up or login with your details

Forgot password? Click here to reset